Lilly Sees More Dealmaking as GLP-1 Wins Expand Market
Eli Lilly’s GLP-1 drugs have changed the game in obesity and diabetes. This article explains why Lilly Sees More Deal...
Identify the right moments to revise your spending plan so your budget remains responsive to changes in income and expenses.
22,044 articlesEli Lilly’s GLP-1 drugs have changed the game in obesity and diabetes. This article explains why Lilly Sees More Deal...
A flood of AI-focused stock offerings could add trillions in market value and test whether buyers can keep up with ne...
Investors are watching Redwire as a multifaceted space tech company. This article explains how redwire's space busine...
Rent is due on the first, but most workers are paid on varied schedules. A growing body of data points to a hidden co...
Range secured an $8.3 million funding round this mid-June 2026, aimed at unifying fiat and stablecoin compliance on a...
A renewed push around crypto governance rekindles the long-standing debate over direct democracy in DAOs. The discuss...
A surge in viral public whale liquidations on Hyperliquid is turning whale activity into a real-time trading signal, ...
SoFi is betting big on product innovation to lift growth. This deep dive explains what the latest move could mean for...
Quantum stocks jump on optimism about next-gen tech, yet analysts caution that lofty valuations outpace current earni...
A USMCA review is on the radar as supply chains evolve and tariffs shift. This article breaks down why extending the ...
Applied Optoelectronics surged 251% year-to-date on soaring AI data-center demand, while the Invesco Semiconductors E...
Bitcoin climbed through the 65,000 level, signaling fresh momentum. Traders weigh whether the rally will last or fade...